SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-005943
Filing Date
2019-03-04
Accepted
2019-03-04 19:56:30
Documents
1
Period of Report
2019-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4009
  Complete submission text file 0000899243-19-005943.txt   5448
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Issuer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALLENA PHARMACEUTICALS, INC. ONE NEWTOWN EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address
WHOLIHAN EDWARD (Reporting) CIK: 0001719764 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38268 | Film No.: 19656172